Related Experiment Videos
Hyperprolactinemia and impotence: why, when and how to investigate
M P Leonard1, C J Nickel, A Morales
1Department of Urology, Queen's University, Kingston, Ontario, Canada.
The Journal of Urology
|October 1, 1989
Summary
Hyperprolactinemia, elevated prolactin levels, can contribute to erectile dysfunction. While medical management is often successful, lowering prolactin does not always restore erectile function.
Area of Science:
- Endocrinology
- Urology
- Reproductive Medicine
Background:
- Hyperprolactinemia's role in erectile dysfunction (ED) remains unclear.
- Drug-induced hyperprolactinemia and prolactinomas cause significant prolactin elevation and hypogonadotropic hypogonadism.
- Erectile dysfunction affects a substantial portion of the male population, with various underlying causes.
Purpose of the Study:
- To investigate the prevalence and etiology of hyperprolactinemia in impotent patients.
- To assess the impact of hyperprolactinemia on erectile function.
- To evaluate the effectiveness of medical management for hyperprolactinemia-associated ED.
Main Methods:
- Prospective investigation of 1,236 impotent patients.
- Serum prolactin levels were measured.
- Etiology of hyperprolactinemia was determined in a subset of patients (n=34).
Main Results:
- 5.3% of impotent patients exhibited elevated serum prolactin levels.
- The primary causes of hyperprolactinemia were idiopathic (47.1%) and drug-induced (29%).
- Medical management improved erectile function in many cases, but restoration was not universal.
Conclusions:
- Hyperprolactinemia is a contributing factor in a small percentage of erectile dysfunction cases.
- Identifying and managing the cause of hyperprolactinemia is crucial.
- Successful prolactin level reduction does not guarantee complete recovery of erectile function.